ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 736157 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 736157; 2) Community: the network communities that were significantly associated with the response to NSC 736157; 3) Molecule: the relationships between components within communities and NSC 736157; 4) MDR: the compounds that were significantly associated with the NSC 736157.

NSC Compound Enrichment Correlation
NSC 102051 Null 0.0430505868034761 0.1605287
NSC 104801 Cytembena 0.0430505868034761 0.091638219
NSC 105132 Deoxycamptothecin 0.0430505868034761 0.098764136
NSC 113423 NSC 113423 0.0430505868034761 -0.16335447
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.0430505868034761 0.14764911
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 0.0430505868034761 0.09465444
NSC 164970 Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- 0.0430505868034761 -0.021862792
NSC 176323 Camptothecin Derivative 0.0430505868034761 0.18441529
NSC 201873 Null 0.0430505868034761 -0.10461759
NSC 217697 Quinoline, 6,6'-methylenebis[1,2-dihydro-2,2,4-trimethyl]- 0.0430505868034761 -0.078751184
Total:90  Current:77    [First] [Prev] [Next] [Last]